Watery Diarrhoea and Mounjaro: Deciding When to Ride It Out and When to Act

Watery diarrhoea is a recognised, documented side effect of tirzepatide — listed in the Mounjaro Patient Information Leaflet and consistent with NHS guidance on the medicine.
Severe or prolonged episodes risk dehydration, which can put strain on the kidneys; prompt fluid replacement matters.
Persistent severe stomach pain alongside diarrhoea, especially pain reaching the back, warrants urgent medical assessment.
Suspected side effects can be reported directly to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Loose, watery stools are one of the more disruptive side effects some people experience on Mounjaro (tirzepatide). They tend to arrive early in treatment, often in the first few weeks or after a dose increase, and for most people settle down as the body adjusts. That said, the decision you're actually facing isn't whether to worry — it's whether what you're experiencing is the expected kind, or a signal that needs prompt attention. Mounjaro is a prescription-only medicine reviewed by a qualified prescriber before and during treatment, so you're not navigating this alone.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How to think through your symptoms, and when to stop waiting

Why Mounjaro causes watery diarrhoea in the first place

Mounjaro activates two gut-hormone receptors, GIP and GLP-1, that are involved in appetite regulation and blood-sugar control. One of the knock-on effects is that it slows how quickly food moves through the stomach. That change in gastric transit alters the environment further along the digestive tract, and for a significant number of people, the result is loose or watery stools, particularly in the early weeks of treatment.

The NHS medicines page for tirzepatide lists diarrhoea among the common side effects, meaning it affects roughly one in ten or more people who take the medicine. The watery quality, rather than just looseness, reflects how quickly the gut is moving fluid that would normally be reabsorbed. It is unpleasant, but it is mechanistically predictable.

Episodes most often peak in the days following a new pen or after moving up a dose. If you started 5 mg last Tuesday, watery stools mid-week are more likely tied to the adjustment than to anything else. Most people find the pattern settles within one to three weeks as the gut recalibrates, though this varies by individual, and some people experience diarrhoea throughout treatment at a lower level.

Factors that shift the decision toward managing at home

The key question is whether your symptoms fit the expected pattern or have drifted outside it. Features that generally sit in the manageable category: onset within the first couple of weeks of a new dose, loose or watery consistency without visible blood, passing in under a week, and an ability to keep fluids down. The full side-effect picture for Mounjaro covers how nausea, constipation and gut discomfort interact with diarrhoea episodes, which can help you recognise where yours sits.

At home, the practical priorities are hydration and salt balance. Water alone is less effective than water alongside foods or drinks containing some electrolytes, plain rice, toast, or diluted fruit juice alongside plain water all help. Avoid high-fat foods while symptoms are active, since fat intake can aggravate GI symptoms on a GLP-1 or dual agonist medicine. Some people find smaller, more frequent meals easier to manage than three full ones.

Timing matters more than people expect. If your dose lands on a Friday and symptoms peak over the weekend, replacing fluids can be harder than midweek, something worth factoring in if you have flexibility over when you administer your weekly injection. That said, consistency of day matters too, so discuss any change with your prescriber rather than shifting it unilaterally.

When watery diarrhoea after Mounjaro needs medical attention

Some features should prompt you to contact a GP or call 111 rather than waiting for things to improve. Diarrhoea that has lasted more than a week without any sign of settling, or that is so frequent you cannot maintain adequate hydration, is outside the expected adjustment window. Signs of dehydration (feeling dizzy when you stand up, very dark urine, a dry mouth, or passing very little urine) mean you need to act that day, not the next morning.

Severe abdominal pain is the more urgent signal. In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines, specifically highlighting acute pancreatitis as a serious but infrequent risk: the key symptom pattern is intense, persistent stomach pain that radiates toward the back, which may or may not come with vomiting. That is not a wait-and-see symptom. Seek emergency care. You can read more about what the clinical picture looks like when diarrhoea after Mounjaro crosses into a concern, including the distinction between gastric adjustment and something more acute.

If you notice blood in your stools at any point, or a fever alongside gut symptoms, contact your GP. And if something simply feels wrong in a way that goes beyond the expected early-adjustment experience, that instinct is worth following up on. Our prescribers are reachable through our aftercare team, seven days a week, for exactly these questions.

Reporting side effects and what happens next

If you experience watery diarrhoea that you feel was significant (whether or not it needed medical attention) reporting it via the MHRA Yellow Card scheme helps build the safety picture for this medicine. Mounjaro carries a Black Triangle (▼) status, meaning the MHRA actively requests reports from patients and healthcare professionals as part of ongoing monitoring. You don't need to be certain that Mounjaro caused the symptom to report it; suspicion is enough.

Within your own treatment, persistent or severe GI side effects are sometimes a signal that the current dose is moving up faster than your body is comfortable with. A prescriber can discuss whether the titration pace is right for you, or whether supportive measures might help. That conversation is part of the clinical review that comes with every prescription at nume, it's not just a formality. If you'd like to understand what else falls within the broader category, the overview of Mounjaro and diarrhoea covers the full range of presentations people report.

For those still weighing whether Mounjaro is suitable for them, our prescribers discuss suitability and side effects openly as part of the consultation. Check your eligibility and start a free consultation to see whether treatment is clinically appropriate for you.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions